The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet’s disease
Autor: | Ali Yalçındağ, Yeşim Gedik-Oğuz, F. Nilüfer Yalçındağ |
---|---|
Rok vydání: | 2013 |
Předmět: |
Adult
Male Vascular Endothelial Growth Factor A medicine.medical_specialty Eye Diseases Angiogenin Basic fibroblast growth factor Enzyme-Linked Immunosorbent Assay Behcet's disease Gastroenterology Pathogenesis Young Adult Cellular and Molecular Neuroscience chemistry.chemical_compound Internal medicine medicine Humans Aged business.industry Behcet Syndrome Ribonuclease Pancreatic Middle Aged medicine.disease Sensory Systems Pathophysiology Vascular endothelial growth factor Ophthalmology chemistry Vascular endothelial growth factor C Cancer research Female Fibroblast Growth Factor 2 business Uveitis |
Zdroj: | Graefe's Archive for Clinical and Experimental Ophthalmology. 251:1807-1812 |
ISSN: | 1435-702X 0721-832X |
DOI: | 10.1007/s00417-013-2322-7 |
Popis: | The aim of this study was to investigate the possible role of angiogenin, vascular endothelial growth factor, (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of BD. Sixty-five patients with BD and 21 healthy control subjects were included in the study, and serum angiogenin, bFGF, and VEGF concentrations were measured by using in-vitro enzyme immunoassay (ELISA) kits according to the manufacturer’s instructions. The median serum angiogenin level was significantly higher in patients with BD (391.8; range:151.6–594.8 pg/ml) than controls (298.8; range:241.9–449.6 pg/ml) (p = 0.001). The levels were similar in both ocular and non-ocular BD patients (p = 0.537). The mean serum bFGF level was higher in patients with BD (38.8 ± 12.3 pg/ml) than controls (33.2 ± 11.3 pg/ml); the median serum VEGF level was also higher in BD patients (239.7; range:53–991.3 pg/ml) than controls (189.4; range:53.6–357.9 pg/ml). But these differences were not statistically significant. Serum bFGF and VEGF levels were also not different statistically in ocular and non-ocular Behcet’s patients. There was no statistically significant relationship between serum angiogenin, bFGF, and VEGF levels and the presence of active eye disease or anatomic location of uveitis. While there was a correlation of borderline significance in angiogenin levels between the patients with anterior uveitis and panuveitis (p = 0.053), we did not obtain any correlation between serum angiogenin, bFGF, and VEGF levels and the duration of BD. This study suggests that angiogenin may be associated with pathophysiology of BD, and highlights the need of further investigation of the role of angiogenin, bFGF, and VEGF serum levels in BD susceptibility and its clinical manifestations. |
Databáze: | OpenAIRE |
Externí odkaz: |